CareLit Fachartikel

Updated results and exploratory analysis of ESR1 mutations (ESR1m) circulating tumor DNA (ctDNA) dynamics from SERENA-6, a phase 3 trial of camizestrant+CDK4/6 inhibitor (CDK4/6i)…

W Janni, F C Bidard, E L Mayer, Y H Park, C X Ma, M Cristofanilli, G Bianchini, K Kalinsky, SK L Chia, A Brufsky, P A Fasching, Z Nowecki, J Pascual, E Gal-Yam, W-P Chung, S-A Im, A Zambelli, F Dalenc, M Oliveira, S Fox, C Morrow, C Huang Bartlett, N C Turner · Senologie - Zeitschrift für Mammadiagnostik und -therapie · 2026 · Heft 02 · S. e18-e19

Dokument
983419
CareLit-ID
Jahr
2026
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Senologie - Zeitschrift für Mammadiagnostik und -therapie
Autor:innen
W Janni, F C Bidard, E L Mayer, Y H Park, C X Ma, M Cristofanilli, G Bianchini, K Kalinsky, SK L Chia, A Brufsky, P A Fasching, Z Nowecki, J Pascual, E Gal-Yam, W-P Chung, S-A Im, A Zambelli, F Dalenc, M Oliveira, S Fox, C Morrow, C Huang Bartlett, N C Turner
Ausgabe
Heft 02 / 2026
Jahrgang 23
Seiten
e18-e19
Erschienen: 2026-05-01 00:00:00
ISSN
1611-6453
DOI
10.1055/s-0046-1819777

Zusammenfassung

Updated results and exploratory analysis of ESR1 mutations (ESR1m) circulating tumor DNA (ctDNA) dynamics from SERENA-6, a phase 3 trial of camizestrant+CDK4/6 inhibitor (CDK4/6i) for emergent ESR1 mutations (ESR1m) during first-line (1L) endocrine-based therapy and ahead of disease progression in patients with HR+/HER2- advanced breast cancer (aBC)

Schlagworte

Breast Tumor Senologie - Zeitschrift für Mammadiagnostik und -therapie